AGEN Message Board | Agenus Inc.

whytestocks: $AGEN News Article - Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI

whytestocks · 2023-05-03EDT06:05:51-04:00

AGEN Message Board | Agenus Inc. whytestocks: $AGEN News Article - Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI

home / stock / agen / agen message board

AGEN AGEN Quote AGEN Short AGEN News AGEN Articles AGEN Message Board

New Post

Message Board | Agenus Inc. (NASDAQ:AGEN)

Subject	By	Source	When
whytestocks: $AGEN News Article - Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI	whytestocks	investorshangout	05/03/2023 6:35:51 PM
shalbyj: TheStreetReports: AI Biotech Stocks to Watch 2023: $IPA, $ONTX, $AGEN, $PBIO https://www.ma	shalbyj	investorshangout	04/25/2023 1:37:15 PM
whytestocks: $AGEN News Article - Agenus Receives Fast Track Designation for Botensilimab and Balsti	whytestocks	investorshangout	04/17/2023 12:00:59 PM
whytestocks: $AGEN News Article - Agenus' Botensilimab in Combination with Balstilimab Shows 33% Dur	whytestocks	investorshangout	03/27/2023 3:10:50 PM
whytestocks: $AGEN News Article - Best Penny Stocks To Buy Now: 3 To Watch Before Next Week	whytestocks	investorshangout	03/15/2023 8:20:47 PM
whytestocks: $AGEN News Article - Agenus to Present Botensilimab Data in Oral Plenary Session at the	whytestocks	investorshangout	02/28/2023 6:50:48 PM
whytestocks: $AGEN News Article - Agenus to Provide Corporate Update and Fourth Quarter & Full Year	whytestocks	investorshangout	02/28/2023 6:45:53 PM
... B.Riley psswd is in immediate registration confirmation	Doktornolittle	investorshub	01/23/2023 1:39:04 PM
B Riley would not allow me to view	Doktornolittle	investorshub	01/19/2023 4:00:47 PM
SITC Oral Presentation on BOT w/wo BAL tomorrow	Doktornolittle	investorshub	11/11/2022 1:21:03 PM
whytestocks: $AGEN News Article - Agenus to Provide Corporate Update and Second Quarter 2022 Financi	whytestocks	investorshangout	07/27/2022 12:35:53 PM
znewcar1: AGEN 22% v11,5M c2.41 f282,8M H2.42 ML1.25	znewcar1	investorshangout	07/05/2022 8:23:15 PM
whytestocks: $AGEN News Article - Agenus to Participate at William Blair's Biotech Focus Conference	whytestocks	investorshangout	06/30/2022 12:35:50 PM
znewcar1: AGEN 2% $1.64 v2M+f271M was 183M 21M ago. 50 AGEN 23% v19,8M c5.19 f183M H5.3809/10/2020	znewcar1	investorshangout	06/03/2022 7:47:02 PM
whytestocks: $AGEN News Article - Agenus Corporate Update and First Quarter 2022 Financial Report	whytestocks	investorshangout	05/10/2022 5:35:49 PM
whytestocks: $AGEN News Article - Agenus to Provide Corporate Update and Fourth Quarter & Full Year	whytestocks	investorshangout	02/15/2022 9:45:54 PM
$AGEN Agenus initiated with a Buy at H.C. Wainwright	stockguard	investorshub	12/16/2021 1:24:16 PM
$11 from $12. Buy rating. Analyst has been	north40000	investorshub	12/07/2021 4:09:37 AM
what was the B Riley target price?	investtemp	investorshub	12/06/2021 8:34:01 PM
B. Riley bullish on Novavax, Agenus amid Omicron	stockguard	investorshub	12/06/2021 8:11:10 PM

Stock Information

Get AGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

Agenus Inc. Company Name:

AGEN Stock Symbol:

NASDAQ Market:

-0.21% G/L:

$5.18 Last:

903,672 Volume:

$4.87 Open:

$5.18 Close:

Agenus Inc. Website:

Agenus Inc. Logo

AGEN - Investors Turn to Cancer Breakthroughs as Federal Funding Faces Deep Cuts

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – With cancer cases rising and treatment costs hitting new highs, the private sector is under growing pressure to lead the next wave of innovation. Experts are now sounding...
AGEN - Agenus' BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3

Agenus Inc. (Nasdaq: AGEN) a leader in immuno-oncology innovation, today announced that its botensilimab and balstilimab (BOT/BAL) combination achieved a two-year survival rate of 42% along with a now more mature 21-month median overall survival (OS) in an expanded cohort of 123 patients with mic...
AGEN - Investors Bet on Biotech as Public Cancer Research Hits a Wall

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – As cancer rates continue to climb worldwide, the race to develop better, faster, and more affordable treatments has never been more urgent. Industry forecasters now proje...